Physician profile
Kathy Yu
NPI 1255587762
$8,054.67
in general payments reported to CMS, 2019-2025
16 companies · $606 in 2025
The $606 reported for 2025 was more than what 80% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,265 · 2020: $1,571 · 2021: $1,415 · 2022: $1,141 · 2023: $683 · 2024: $372 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,132.15 | 2019-2025 | Xpress Ent Dilation System, Xpress Loprofile, Clarifix |
| Intersect Ent, INC. | $930.03 | 2019-2022 | |
| Medtronic, INC. | $200.54 | 2022-2023 | Propel |
| Genzyme Corporation | $180.96 | 2024-2025 | |
| Kyowa Kirin, INC. | $154.80 | 2025 | |
| Aerin Medical INC. | $93.05 | 2023-2025 | |
| Glaxosmithkline, LLC. | $77.89 | 2024-2025 | Nucala |
| Hikma Pharmaceuticals USA | $61.10 | 2023-2024 | Ryaltris |
| Regeneron Healthcare Solutions, INC. | $55.72 | 2024 | Dupixent |
| Optinose US, INC. | $46.62 | 2024-2025 | |
| Vertical Pharmaceuticals, LLC | $32.64 | 2023-2024 | Dsuvia |
| Medtronic USA, INC. | $21.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.25 | 2019 | |
| Mckesson Medical-Surgical, INC. | $19.17 | 2020 | |
| Acclarent, INC | $16.39 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.